These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23567428)

  • 21. Costs and quality of life of multiple sclerosis in Spain.
    Kobelt G; Berg J; Lindgren P; Izquierdo G; Sánchez-Soliño O; Pérez-Miranda J; Casado MA;
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S65-74. PubMed ID: 17310340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time use and costs of institutionalised elderly persons with or without dementia: results from the Nordanstig cohort in the Kungsholmen Project--a population based study in Sweden.
    Nordberg G; Wimo A; Jönsson L; Kåreholt I; Sjölund BM; Lagergren M; von Strauss E
    Int J Geriatr Psychiatry; 2007 Jul; 22(7):639-48. PubMed ID: 17225239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The economic impact of dementia in Belgium: results of the National Dementia Economic Study (NADES).
    Scuvee-Moreau J; Kurz X; Dresse A;
    Acta Neurol Belg; 2002 Sep; 102(3):104-13. PubMed ID: 12400248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of memantine for moderate to severe Alzheimer's disease in Sweden.
    Jönsson L
    Am J Geriatr Pharmacother; 2005 Jun; 3(2):77-86. PubMed ID: 16129384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Costs of care for people with dementia just before and after nursing home placement: primary data from eight European countries.
    Wübker A; Zwakhalen SM; Challis D; Suhonen R; Karlsson S; Zabalegui A; Soto M; Saks K; Sauerland D
    Eur J Health Econ; 2015 Sep; 16(7):689-707. PubMed ID: 25069577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost of dementia in the pre-enlargement countries of the European Union.
    Luengo-Fernandez R; Leal J; Gray AM
    J Alzheimers Dis; 2011; 27(1):187-96. PubMed ID: 21860095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease.
    Zhu CW; Scarmeas N; Torgan R; Albert M; Brandt J; Blacker D; Sano M; Stern Y
    Neurology; 2006 Sep; 67(6):998-1005. PubMed ID: 16914696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal costs of caring for people with Alzheimer's disease.
    Gillespie P; O'Shea E; Cullinan J; Buchanan J; Bobula J; Lacey L; Gallagher D; Mhaolain AN; Lawlor B;
    Int Psychogeriatr; 2015 May; 27(5):847-56. PubMed ID: 25248030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care.
    Behrens S; Rattinger GB; Schwartz S; Matyi J; Sanders C; DeBerard MS; Lyketsos CG; Tschanz JT
    Int Psychogeriatr; 2018 Oct; 30(10):1499-1507. PubMed ID: 29559029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Costs and quality of life of multiple sclerosis in Sweden.
    Berg J; Lindgren P; Fredrikson S; Kobelt G
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S75-85. PubMed ID: 17310342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic evaluation of cholinesterase inhibitor therapy for dementia: comparison of Alzheimer's disease and Dementia with Lewy bodies.
    Gustavsson A; Van Der Putt R; Jönsson L; McShane R
    Int J Geriatr Psychiatry; 2009 Oct; 24(10):1072-8. PubMed ID: 19639600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Costs and quality of life of multiple sclerosis in Switzerland.
    Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Predictors of long-term institutionalization in patients with Alzheimer's disease: role of caregiver burden].
    Hirono N; Tsukamoto N; Inoue M; Moriwaki Y; Mori E
    No To Shinkei; 2002 Sep; 54(9):812-8. PubMed ID: 12428367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Net costs of dementia by disease stage.
    Leicht H; Heinrich S; Heider D; Bachmann C; Bickel H; van den Bussche H; Fuchs A; Luppa M; Maier W; Mösch E; Pentzek M; Rieder-Heller SG; Tebarth F; Werle J; Weyerer S; Wiese B; Zimmermann T; König HH;
    Acta Psychiatr Scand; 2011 Nov; 124(5):384-95. PubMed ID: 21838738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost and care of patients with Alzheimer's disease: clinical predictors in German health care settings.
    Reese JP; Hessmann P; Seeberg G; Henkel D; Hirzmann P; Rieke J; Baum E; Dannhoff F; Müller MJ; Jessen F; Geldsetzer MB; Dodel R
    J Alzheimers Dis; 2011; 27(4):723-36. PubMed ID: 21876256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study.
    Lenox-Smith A; Reed C; Lebrec J; Belger M; Jones RW
    BMC Geriatr; 2016 Nov; 16(1):195. PubMed ID: 27887645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cost of Alzheimer's disease in managed care: a cross-sectional study.
    Leon J; Neumann PJ
    Am J Manag Care; 1999 Jul; 5(7):867-77. PubMed ID: 10557408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer's disease clinical trials.
    Kahle-Wrobleski K; Fillit H; Kurlander J; Reed C; Belger M
    Eur J Health Econ; 2015 Dec; 16(9):995-1004. PubMed ID: 25410743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Healthcare resource utilization and cost in dementia: are there differences between patients screened positive for dementia with and those without a formal diagnosis of dementia in primary care in Germany?
    Michalowsky B; Eichler T; Thyrian JR; Hertel J; Wucherer D; Hoffmann W; Flessa S
    Int Psychogeriatr; 2016 Mar; 28(3):359-69. PubMed ID: 26446797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of time to institutionalisation and related healthcare and societal costs in a community-based cohort of patients with Alzheimer's disease dementia.
    Belger M; Haro JM; Reed C; Happich M; Argimon JM; Bruno G; Dodel R; Jones RW; Vellas B; Wimo A
    Eur J Health Econ; 2019 Apr; 20(3):343-355. PubMed ID: 30178148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.